PMID: 42489387

Cardiovascular and Cerebrovascular Outcomes Risk Reduction Associated With Semaglutide vs Tirzepatide: A Target Trial Emulation.

Azzam Ahmed Y, Essibayi Muhammed Amir, Rai Pranjal, Salim Hamza A, Alhasan Mustafa S, Anindo Mohammad, Hashem Anas, Dmytriw Adam A, Altschul David J, Yedavalli Vivek S

JACC. Advances · 2026

Vol. 5, Issue 7, pp. 102917

View on PubMed DOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.